Cash flow Akamai Technologies, Inc.

Equities

AKAM

US00971T1016

IT Services & Consulting

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-13 pm EST			5-day change	1st Jan Change
88.86 ^USD	-2.64%		+0.14%	+1.85%

Jan. 12	Akamai Technologies Positioned for Broad-Based Growth, Morgan Stanley Says	MT
Jan. 12	Morgan Stanley Upgrades Akamai Technologies to Overweight From Underweight, Adjusts PT to $115 From $83	MT

7385bff69443245b2668e2d730d922b.3j7owPr0pNOOnSjI8LGXU-YoZ_EKl90VspTSxj8IYIo.60jF7ZGMkKrZ3F_-pcTCMo14P8lr-eRFx_7qkHJPE8iSXd22r5adoPz7Rw

Published financial data: AKAMAI TECHNOLOGIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.2B	3.46B	3.62B	3.81B	3.99B
Total Revenues	3.2B	3.46B	3.62B	3.81B	3.99B
Cost of Goods Sold, Total	1.13B	1.27B	1.38B	1.51B	1.62B
Gross Profit	2.07B	2.19B	2.24B	2.3B	2.37B
Selling General & Admin Expenses, Total	1.03B	1B	1.07B	1.12B	1.17B
R&D Expenses	269M	335M	389M	405M	471M
Amortization of Goodwill and Intangible Assets - (IS)	42.05M	48.02M	64.98M	66.75M	92.08M
Other Operating Expenses, Total	1.34B	1.39B	1.52B	1.6B	1.73B
Operating Income	721M	807M	719M	707M	636M
Interest Expense, Total	-69.12M	-72.33M	-11.1M	-17.71M	-27.12M
Interest And Investment Income	29.12M	15.62M	3.26M	45.19M	100M
Net Interest Expenses	-40M	-56.71M	-7.84M	27.48M	73.16M
Income (Loss) On Equity Invest.	-13.11M	-14.01M	-7.64M	1.48M	-
Currency Exchange Gains (Loss)	-9.68M	-1.9M	-2.17M	-12.61M	-14.46M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	659M	735M	701M	724M	695M
Restructuring Charges	-37.29M	-10.74M	-13.53M	-56.64M	-95.44M
Merger & Related Restructuring Charges	-	-	-	-13.35M	-7.5M
Gain (Loss) On Sale Of Investments	7.23M	3.68M	-8.26M	311K	-5.1M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-25.58M	-13.32M	-29.05M	-	-
EBT, Incl. Unusual Items	603M	714M	650M	654M	587M
Income Tax Expense	45.92M	62.57M	127M	106M	82.1M
Earnings From Continuing Operations	557M	652M	524M	548M	505M
Net Income to Company	557M	652M	524M	548M	505M
Net Income - (IS)	557M	652M	524M	548M	505M
Net Income to Common Incl Extra Items	557M	652M	524M	548M	505M
Net Income to Common Excl. Extra Items	557M	652M	524M	548M	505M
Per Share Items
Net EPS - Basic	3.43	4.01	3.29	3.59	3.34
Basic EPS - Continuing Operations	3.43	4.01	3.29	3.59	3.34
Basic Weighted Average Shares Outstanding	162M	163M	159M	153M	151M
Net EPS - Diluted	3.37	3.93	3.26	3.52	3.27
Diluted EPS - Continuing Operations	3.37	3.93	3.26	3.52	3.27
Diluted Weighted Average Shares Outstanding	165M	166M	160M	155M	154M
Normalized Basic EPS	2.53	2.82	2.75	2.97	2.87
Normalized Diluted EPS	2.49	2.77	2.73	2.91	2.81
American Depositary Receipts Ratio (ADR)	0.08	0.08	0.08	0.08	0.08
Supplemental Items
EBITDA	1.04B	1.19B	1.15B	1.1B	1.12B
EBITA	763M	855M	784M	774M	728M
EBIT	721M	807M	719M	707M	636M
EBITDAR	1.29B	1.46B	1.44B	1.43B	1.5B
Effective Tax Rate - (Ratio)	7.62	8.76	19.48	16.26	13.99
Current Domestic Taxes	3.58M	20.34M	59.02M	30.14M	30.87M
Current Foreign Taxes	76.16M	90.03M	173M	99.22M	121M
Total Current Taxes	79.74M	110M	232M	129M	152M
Total Deferred Taxes	-33.82M	-47.79M	-105M	-22.99M	-70.27M
Normalized Net Income	412M	459M	438M	452M	434M
Interest Capitalized	4.33M	3.67M	293K	462K	1.28M
Interest on Long-Term Debt	73.45M	76M	11.39M	18.17M	28.4M
Supplemental Operating Expense Items
Marketing Expenses	39.27M	40.55M	55.03M	59.15M	53.89M
Selling and Marketing Expenses	510M	462M	500M	532M	557M
General and Administrative Expenses	424M	439M	462M	503M	528M
Research And Development Expense From Footnotes	428M	500M	557M	583M	640M
Net Rental Expense, Total	246M	271M	291M	333M	381M
Imputed Operating Lease Interest Expense	53.15M	58.45M	8.79M	12.56M	18.88M
Imputed Operating Lease Depreciation	193M	212M	282M	321M	362M
Stock-Based Comp., COGS (Total)	52.86M	57.39M	57.15M	73.79M	61.18M
Stock-Based Comp., R&D Exp. (Total)	48.86M	65.95M	78.12M	124M	152M
Stock-Based Comp., S&M Exp. (Total)	65.26M	46.34M	47.79M	66.45M	77.59M
Stock-Based Comp., G&A Exp. (Total)	58.47M	63.32M	62.93M	94.32M	102M
Stock-Based Comp., Other (Total)	1.57M	2.15M	2.51M	2.52M	2.97M
Total Stock-Based Compensation	227M	235M	248M	361M	396M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	353M	537M	542M	489M	518M
Short Term Investments	745M	541M	563M	375M	1.08B
Total Cash And Short Term Investments	1.1B	1.08B	1.11B	864M	1.6B
Accounts Receivable, Total	660M	676M	679M	724M	728M
Total Receivables	660M	676M	679M	724M	728M
Prepaid Expenses	65.75M	74.07M	98.83M	96.31M	98.16M
Other Current Assets, Total	106M	92.24M	86.21M	120M	156M
Total Current Assets	1.93B	1.92B	1.97B	1.8B	2.58B
Gross Property Plant And Equipment	4.31B	4.61B	4.91B	5.61B	6.16B
Accumulated Depreciation	-2.04B	-2.26B	-2.56B	-2.88B	-3.16B
Net Property Plant And Equipment	2.27B	2.35B	2.35B	2.73B	3B
Long-term Investments	1.42B	1.1B	321M	1.43B	296M
Goodwill	1.67B	2.16B	2.76B	2.85B	3.15B
Other Intangibles, Total	235M	313M	442M	536M	728M
Deferred Tax Assets Long-Term	107M	168M	338M	418M	483M
Deferred Charges Long-Term	23.2M	30.44M	29.07M	42.74M	59M
Other Long-Term Assets, Total	103M	104M	87.45M	81.6M	71.88M
Total Assets	7.76B	8.14B	8.3B	9.9B	10.37B
Liabilities
Accounts Payable, Total	119M	110M	145M	147M	130M
Accrued Expenses, Total	330M	339M	291M	282M	295M
Current Portion of Long-Term Debt	-	-	-	-	1.15B
Current Portion of Leases	155M	176M	196M	223M	259M
Current Income Taxes Payable	50.81M	72.95M	76.46M	70.02M	76.38M
Unearned Revenue Current, Total	76.6M	86.52M	105M	108M	149M
Other Current Liabilities	27.76M	6.62M	5.23M	6.44M	32.52M
Total Current Liabilities	758M	790M	819M	836M	2.09B
Long-Term Debt	1.91B	1.98B	2.29B	3.54B	2.4B
Long-Term Leases	715M	707M	693M	775M	830M
Unearned Revenue Non Current	5.26M	25.34M	22.12M	23.01M	26.31M
Deferred Tax Liability Non Current	37.46M	40.97M	18.4M	24.62M	16.07M
Other Non Current Liabilities	89.83M	68.75M	105M	106M	130M
Total Liabilities	3.51B	3.61B	3.94B	5.3B	5.49B
Common Stock, Total	1.63M	1.6M	1.56M	1.51M	1.56M
Additional Paid In Capital	3.66B	3.34B	2.58B	2.22B	2.62B
Retained Earnings	605M	1.26B	1.92B	2.47B	2.97B
Treasury Stock	-	-	-	-	-558M
Comprehensive Income and Other	-20.2M	-69.1M	-140M	-95.33M	-156M
Total Common Equity	4.25B	4.53B	4.36B	4.6B	4.88B
Total Equity	4.25B	4.53B	4.36B	4.6B	4.88B
Total Liabilities And Equity	7.76B	8.14B	8.3B	9.9B	10.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	163M	160M	156M	152M	150M
ECS Total Common Shares Outstanding	163M	161M	156M	151M	150M
Book Value / Share	26.13	28.22	27.86	30.4	32.52
Tangible Book Value	2.34B	2.06B	1.15B	1.21B	1B
Tangible Book Value Per Share	14.39	12.84	7.38	8	6.66
Total Debt	2.78B	2.86B	3.17B	4.54B	4.63B
Net Debt	280M	693M	1.75B	2.24B	2.76B
Debt Equivalent Oper. Leases	1.97B	2.17B	2.33B	2.67B	3.05B
Equity Method Investments, Total	21.6M	7.5M	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.96B	2.1B	2.25B	2.56B	2.77B
Full Time Employees	8.37K	8.7K	9.8K	10.25K	10.7K
Accumulated Allowance for Doubtful Accounts (Supple)	1.82M	1.4M	5.92M	3.47M	3.52M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	557M	652M	524M	548M	505M
Depreciation & Amortization - CF	278M	338M	362M	327M	388M
Amortization of Goodwill and Intangible Assets - (CF)	42.05M	48.02M	64.98M	66.75M	92.08M
Depreciation & Amortization, Total	320M	386M	427M	394M	480M
Amortization of Deferred Charges, Total - (CF)	221M	230M	170M	182M	175M
(Gain) Loss on Sale of Investments - (CF)	-	-	15.9M	-311K	5.07M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	197M	203M	217M	328M	393M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-10.79M	-25.97M	-73.91M	27.23M	-4.78M
Change In Accounts Receivable	-90.38M	-24.1M	-21.21M	-49.2M	-22.3M
Change In Accounts Payable	39.21M	31.52M	-26.5M	-39.82M	344K
Change in Unearned Revenues	-1.32M	-2.86M	16.71M	48K	20.69M
Change in Other Net Operating Assets	-17.4M	-45.09M	25.68M	-41.72M	-33.07M
Cash from Operations	1.22B	1.4B	1.27B	1.35B	1.52B
Capital Expenditure	-551M	-329M	-241M	-579M	-523M
Cash Acquisitions	-128M	-599M	-872M	-106M	-434M
Sale (Purchase) of Intangible assets	-218M	-216M	-217M	-272M	-295M
Investment in Marketable and Equity Securities, Total	-155M	501M	714M	-885M	450M
Other Investing Activities, Total	8.12M	-4.32M	-6.12M	-6.07M	3.97M
Cash from Investing	-1.04B	-647M	-622M	-1.85B	-799M
Short Term Debt Issued, Total	-	-	-	90M	-
Long-Term Debt Issued, Total	-	-	-	1.25B	-
Total Debt Issued	-	-	-	1.34B	-
Short Term Debt Repaid, Total	-	-	-	-90M	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-90M	-
Issuance of Common Stock	59.78M	59.63M	56.46M	62.98M	61.51M
Repurchase of Common Stock	-283M	-621M	-690M	-720M	-731M
Other Financing Activities, Total	-	-268K	-393K	-147M	-10.5M
Cash from Financing	-224M	-562M	-634M	443M	-680M
Foreign Exchange Rate Adjustments	10.94M	-11.38M	-12.92M	3.87M	-12.24M
Net Change in Cash	-40.68M	184M	5.27M	-52.55M	28.61M
Supplemental Items
Cash Interest Paid	5.95M	5.75M	6.16M	6.33M	20.42M
Cash Income Tax Paid (Refund)	79.16M	101M	184M	134M	136M
Levered Free Cash Flow	320M	766M	816M	431M	643M
Unlevered Free Cash Flow	301M	746M	818M	437M	653M
Change In Net Working Capital	87.34M	-508K	13.89M	85.85M	-28.88M
Net Debt Issued / Repaid	-	-	-	1.25B	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.1	6.34	5.46	4.86	3.92
Return on Total Capital	6.75	7	6.02	5.3	4.27
Return On Equity %	14.09	14.84	11.78	12.23	10.66
Return on Common Equity	14.09	14.84	11.78	12.23	10.66
Margin Analysis
Gross Profit Margin %	64.58	63.34	61.88	60.44	59.39
SG&A Margin	32.29	28.94	29.46	29.5	29.34
EBITDA Margin %	32.56	34.49	31.68	28.88	27.96
EBITA Margin %	23.87	24.71	21.67	20.31	18.25
EBIT Margin %	22.56	23.32	19.88	18.56	15.94
Income From Continuing Operations Margin %	17.42	18.83	14.48	14.37	12.65
Net Income Margin %	17.42	18.83	14.48	14.37	12.65
Net Avail. For Common Margin %	17.42	18.83	14.48	14.37	12.65
Normalized Net Income Margin	12.87	13.26	12.12	11.87	10.88
Levered Free Cash Flow Margin	10.02	22.14	22.56	11.31	16.11
Unlevered Free Cash Flow Margin	9.4	21.54	22.63	11.46	16.37
Asset Turnover
Asset Turnover	0.43	0.44	0.44	0.42	0.39
Fixed Assets Turnover	1.53	1.5	1.54	1.5	1.39
Receivables Turnover (Average Receivables)	5.28	5.18	5.34	5.43	5.5
Short Term Liquidity
Current Ratio	2.54	2.43	2.41	2.16	1.23
Quick Ratio	2.32	2.22	2.18	1.9	1.11
Operating Cash Flow to Current Liabilities	1.6	1.78	1.56	1.61	0.73
Days Sales Outstanding (Average Receivables)	69.35	70.44	68.38	67.19	66.58
Average Days Payable Outstanding	41.6	32.86	33.8	35.38	31.32
Long Term Solvency
Total Debt/Equity	65.32	63.11	72.81	98.67	95
Total Debt / Total Capital	39.51	38.69	42.13	49.66	48.72
LT Debt/Equity	61.68	59.23	68.31	93.82	66.14
Long-Term Debt / Total Capital	37.31	36.31	39.53	47.22	33.92
Total Liabilities / Total Assets	45.24	44.34	47.49	53.56	52.95
EBIT / Interest Expense	10.44	11.16	64.78	39.94	23.47
EBITDA / Interest Expense	18.63	20.25	129.51	80.99	55.21
(EBITDA - Capex) / Interest Expense	10.66	15.7	107.77	48.3	35.91
Total Debt / EBITDA	2.16	1.95	2.21	3.16	3.1
Net Debt / EBITDA	0.22	0.47	1.22	1.56	1.85
Total Debt / (EBITDA - Capex)	3.77	2.52	2.65	5.3	4.76
Net Debt / (EBITDA - Capex)	0.38	0.61	1.46	2.62	2.84
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.52	8.23	4.49	5.4	4.7
Gross Profit, 1 Yr. Growth %	8.37	6.14	2.08	2.96	2.88
EBITDA, 1 Yr. Growth %	23.18	14.6	-4.01	-3.91	1.36
EBITA, 1 Yr. Growth %	24.73	11.98	-8.35	-1.24	-5.9
EBIT, 1 Yr. Growth %	25.78	11.85	-10.94	-1.6	-10.03
Earnings From Cont. Operations, 1 Yr. Growth %	16.53	16.98	-19.64	4.57	-7.8
Net Income, 1 Yr. Growth %	16.53	16.98	-19.64	4.57	-7.8
Normalized Net Income, 1 Yr. Growth %	18.45	11.49	-4.54	3.11	-4
Diluted EPS Before Extra, 1 Yr. Growth %	16.21	16.62	-17.05	7.98	-7.1
Accounts Receivable, 1 Yr. Growth %	19.59	2.4	0.49	6.64	0.47
Net Property, Plant and Equip., 1 Yr. Growth %	18.93	3.43	0.15	16.19	9.77
Total Assets, 1 Yr. Growth %	10.81	4.82	2.02	19.23	4.73
Tangible Book Value, 1 Yr. Growth %	24.7	-12.03	-43.96	4.84	-17.42
Common Equity, 1 Yr. Growth %	16.22	6.56	-3.75	5.43	6.12
Cash From Operations, 1 Yr. Growth %	14.81	15.6	-9.25	5.79	12.66
Capital Expenditures, 1 Yr. Growth %	53.11	-40.26	-26.66	139.94	-9.61
Levered Free Cash Flow, 1 Yr. Growth %	-28.52	139.14	6.45	-47.14	49.07
Unlevered Free Cash Flow, 1 Yr. Growth %	-30.58	147.82	9.76	-46.6	49.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.54	9.37	6.34	4.94	5.05
Gross Profit, 2 Yr. CAGR %	8.3	7.25	4.09	2.52	2.92
EBITDA, 2 Yr. CAGR %	21.69	18.13	4.88	-3.96	-1.31
EBITA, 2 Yr. CAGR %	30.41	17.25	1.31	-4.86	-3.6
EBIT, 2 Yr. CAGR %	31.75	17.62	-0.2	-6.39	-5.91
Earnings From Cont. Operations, 2 Yr. CAGR %	36.64	16.75	-3.04	-8.33	-1.81
Net Income, 2 Yr. CAGR %	36.64	16.75	-3.04	-8.33	-1.81
Normalized Net Income, 2 Yr. CAGR %	28.69	13.92	3.16	-0.75	-0.49
Diluted EPS Before Extra, 2 Yr. CAGR %	38.38	16.41	-1.65	-5.36	0.15
Accounts Receivable, 2 Yr. CAGR %	17.28	10.66	1.44	3.52	3.51
Net Property, Plant and Equip., 2 Yr. CAGR %	57.96	10.91	1.77	7.87	12.94
Total Assets, 2 Yr. CAGR %	19.23	7.77	3.41	10.29	11.75
Tangible Book Value, 2 Yr. CAGR %	23.48	4.74	-29.79	-23.35	-6.95
Common Equity, 2 Yr. CAGR %	15.41	11.28	1.27	0.74	5.78
Cash From Operations, 2 Yr. CAGR %	9.77	15.2	2.43	-2.02	9.17
Capital Expenditures, 2 Yr. CAGR %	59.08	-4.36	-33.81	32.65	47.27
Levered Free Cash Flow, 2 Yr. CAGR %	-25.1	29.87	59.55	-24.99	-11.23
Unlevered Free Cash Flow, 2 Yr. CAGR %	-26.47	30.26	64.92	-23.45	-10.65
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.71	8.44	7.72	6.03	4.86
Gross Profit, 3 Yr. CAGR %	8.59	7.58	5.5	3.71	2.64
EBITDA, 3 Yr. CAGR %	16.43	19.29	10.24	1.87	-2.22
EBITA, 3 Yr. CAGR %	21.71	23.97	8.01	0.45	-5.21
EBIT, 3 Yr. CAGR %	22.49	24.77	7.2	-0.67	-7.62
Earnings From Cont. Operations, 3 Yr. CAGR %	35.73	29.74	3.09	-0.57	-8.15
Net Income, 3 Yr. CAGR %	35.73	29.74	3.09	-0.57	-8.15
Normalized Net Income, 3 Yr. CAGR %	18.88	22.7	7.4	3.18	-1.83
Diluted EPS Before Extra, 3 Yr. CAGR %	37.73	30.71	3.98	1.46	-5.94
Accounts Receivable, 3 Yr. CAGR %	12.67	12.09	7.16	3.14	2.49
Net Property, Plant and Equip., 3 Yr. CAGR %	38.11	37.17	7.2	6.37	8.5
Total Assets, 3 Yr. CAGR %	18.64	14.22	5.82	8.44	8.41
Tangible Book Value, 3 Yr. CAGR %	12.1	10.29	-14.97	-19.75	-21.42
Common Equity, 3 Yr. CAGR %	8.13	12.38	6.03	2.64	2.5
Cash From Operations, 3 Yr. CAGR %	14.9	11.68	6.4	3.53	2.65
Capital Expenditures, 3 Yr. CAGR %	29.4	14.77	-12.46	1.68	16.73
Levered Free Cash Flow, 3 Yr. CAGR %	0.83	10.31	21.54	10.4	-5.69
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0.52	10.27	23.04	13.25	-4.31
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.79	8.07	7.76	7.03	6.64
Gross Profit, 5 Yr. CAGR %	7.01	7.33	6.76	5.52	4.46
EBITDA, 5 Yr. CAGR %	8.5	10.52	11.67	9.38	5.46
EBITA, 5 Yr. CAGR %	9.02	11.13	13.11	11.51	3.21
EBIT, 5 Yr. CAGR %	9.01	11.06	12.86	11.22	1.75
Earnings From Cont. Operations, 5 Yr. CAGR %	11.63	15.23	18.64	12.91	1.1
Net Income, 5 Yr. CAGR %	11.63	15.23	18.64	12.91	1.1
Normalized Net Income, 5 Yr. CAGR %	7.48	9.21	12.33	12.72	4.19
Diluted EPS Before Extra, 5 Yr. CAGR %	13.62	16.64	20.37	14.87	2.43
Accounts Receivable, 5 Yr. CAGR %	11.65	12.89	8.04	8.58	5.68
Net Property, Plant and Equip., 5 Yr. CAGR %	24.71	24.02	22.23	24.6	9.46
Total Assets, 5 Yr. CAGR %	13.17	13.23	12.3	12.63	8.15
Tangible Book Value, 5 Yr. CAGR %	5.24	2.22	-7.03	-4.65	-11.85
Common Equity, 5 Yr. CAGR %	6.38	7.04	5.33	7.57	5.93
Cash From Operations, 5 Yr. CAGR %	8.9	10.01	9.74	5.99	7.5
Capital Expenditures, 5 Yr. CAGR %	12.06	12.7	-1.03	21.61	7.79
Levered Free Cash Flow, 5 Yr. CAGR %	1.81	6.67	21.16	-5.46	7.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.01	6.36	21.79	-4.71	8.26